These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2855108)

  • 1. The proliferation rate of intracranial tumors as defined by the monoclonal antibody KI 67. Application of the method to paraffin embedded specimens.
    Böker DK; Stark HJ
    Neurosurg Rev; 1988; 11(3-4):267-72. PubMed ID: 2855108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of the proliferative potential of human brain tumors using the monoclonal antibody Ki-67.
    Deckert M; Reifenberger G; Wechsler W
    J Cancer Res Clin Oncol; 1989; 115(2):179-88. PubMed ID: 2715168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical expression of proliferating cell nuclear antigen (PCNA) in intracranial glioma and meningioma.
    Shih YH; Kadota Y; Sato K; Sueyoshi N; Shirai T
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Apr; 53(4):193-7. PubMed ID: 7911730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical detection of dUTPase in intracranial tumors.
    Romeike BF; Böckeler A; Kremmer E; Sommer P; Krick C; Grässer F
    Pathol Res Pract; 2005; 201(11):727-32. PubMed ID: 16325515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ki-67 immunoreactivity in human central nervous system tumors: a study with MIB 1 monoclonal antibody on archival material.
    Karamitopoulou E; Perentes E; Diamantis I; Maraziotis T
    Acta Neuropathol; 1994; 87(1):47-54. PubMed ID: 7511316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of proliferation and apoptosis in brain gliomas: prognostic and clinical value.
    Heesters MA; Koudstaal J; Go KG; Molenaar WM
    J Neurooncol; 1999; 44(3):255-66. PubMed ID: 10720205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology.
    Burger PC; Shibata T; Kleihues P
    Am J Surg Pathol; 1986 Sep; 10(9):611-7. PubMed ID: 2428262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tenascin distribution in human brain tumours.
    Castellani P; Dorcaratto A; Siri A; Zardi L; Viale GL
    Acta Neurochir (Wien); 1995; 136(1-2):44-50. PubMed ID: 8748826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of human gliomas by a monoclonal antibody both on tissue culture and paraffin-embedded sections.
    Sipos L; Wakabayashi T; Szeifert GT; Fazekas I; Afra D
    Neurol Res; 1992 Jun; 14(3):263-6. PubMed ID: 1355282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas.
    Onda K; Davis RL; Shibuya M; Wilson CB; Hoshino T
    Cancer; 1994 Oct; 74(7):1921-6. PubMed ID: 7521787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between Ki-67 positive cells, growth rate and histological type of human intracranial tumors.
    Patsouris E; Stocker U; Kallmeyer V; Keiditsch E; Mehraein P; Stavrou D
    Anticancer Res; 1988; 8(4):537-44. PubMed ID: 3052245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PCNA and Ki-67 in central nervous system tumors: correlation with the histological type and grade.
    Kayaselçuk F; Zorludemir S; Gümürdühü D; Zeren H; Erman T
    J Neurooncol; 2002 Apr; 57(2):115-21. PubMed ID: 12125971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow-cytometric DNA analysis and immunohistochemical measurement of Ki-67 and BUdR labeling indices in human brain tumors.
    Nishizaki T; Orita T; Furutani Y; Ikeyama Y; Aoki H; Sasaki K
    J Neurosurg; 1989 Mar; 70(3):379-84. PubMed ID: 2536805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas.
    Geiger KD; Stoldt P; Schlote W; Derouiche A
    Am J Pathol; 2000 Dec; 157(6):1785-93. PubMed ID: 11106550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical studies on human brain tumors using anti-Leu 7 monoclonal antibody in paraffin-embedded specimens.
    Motoi M; Yoshino T; Hayashi K; Nose S; Horie Y; Ogawa K
    Acta Neuropathol; 1985; 66(1):75-7. PubMed ID: 3887834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microvessel density in brain tumors.
    Assimakopoulou M; Sotiropoulou-Bonikou G; Maraziotis T; Papadakis N; Varakis I
    Anticancer Res; 1997; 17(6D):4747-53. PubMed ID: 9494601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of proliferating cells in human gliomas using the monoclonal antibody Ki-67.
    Zuber P; Hamou MF; de Tribolet N
    Neurosurgery; 1988 Feb; 22(2):364-8. PubMed ID: 2832782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunostaining for proliferating cell nuclear antigen: its role in determination of proliferation in routinely processed human brain tumor specimens.
    Khoshyomn S; Maier H; Morimura T; Kitz K; Budka H
    Acta Neuropathol; 1993; 86(6):582-9. PubMed ID: 7906072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of gliomas by morphological and immunocytochemical analysis in cell cultures.
    Fazekas I; Kerekes E; Hegedús B; Nyáry I
    Ideggyogy Sz; 2002 May; 55(5-6):173-9. PubMed ID: 12122877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cell kinetics of oligodendroglioma and oligo-astrocytoma--Ki-67 PaP study].
    Shibata T; Burger PC; Kleihues P
    No To Shinkei; 1988 Aug; 40(8):779-85. PubMed ID: 3052541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.